Ascentage Pharma Group International (AAPG) Current Assets (2023 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Current Assets for 3 consecutive years, with $415.1 million as the latest value for Q4 2025.
- For Q4 2025, Current Assets rose 102.27% year-over-year to $415.1 million; the TTM value through Dec 2025 reached $415.1 million, up 102.27%, while the annual FY2025 figure was $421.0 million, 108.46% up from the prior year.
- Current Assets hit $415.1 million in Q4 2025 for Ascentage Pharma Group International, up from $205.2 million in the prior quarter.
- Across five years, Current Assets topped out at $415.1 million in Q4 2025 and bottomed at $186.7 million in Q4 2023.
- Average Current Assets over 3 years is $269.0 million, with a median of $205.2 million recorded in 2024.
- Year-over-year, Current Assets increased 9.93% in 2024 and then surged 102.27% in 2025.
- Ascentage Pharma Group International's Current Assets stood at $186.7 million in 2023, then increased by 9.93% to $205.2 million in 2024, then soared by 102.27% to $415.1 million in 2025.
- According to Business Quant data, Current Assets over the past three periods came in at $415.1 million, $205.2 million, and $186.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.